Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.205 USD | +3.32% | +5.39% | -12.40% |
Apr. 15 | Sector Update: Health Care Stocks Gain Monday Afternoon | MT |
Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |
Business Summary
Number of employees: 1,543
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Vaccines
100.0
%
| 1,982 | 100.0 % | 984 | 100.0 % | -50.36% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1,982 | 100.0 % | 984 | 100.0 % | -50.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Jacobs
CEO | Chief Executive Officer | 57 | 23-01-22 |
John Trizzino
PSD | President | 64 | 14-03-09 |
James Kelly
DFI | Director of Finance/CFO | 58 | 21-08-15 |
Troy Morgan
CMP | Compliance Officer | - | 21-04-18 |
Raburn Mallory
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Seth Toback
CTO | Chief Tech/Sci/R&D Officer | - | 20-06-30 |
Gale Smith
CTO | Chief Tech/Sci/R&D Officer | - | 03-12-31 |
Filip Dubovsky
CTO | Chief Tech/Sci/R&D Officer | 59 | 20-06-16 |
Biegie Lee
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Silvia Taylor
IRO | Public Communications Contact | - | 20-06-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Rodgers
BRD | Director/Board Member | 57 | 22-10-28 |
Gregg Alton
BRD | Director/Board Member | 58 | 20-10-31 |
David Mott
BRD | Director/Board Member | 58 | 20-06-15 |
James Young
CHM | Chairman | 71 | 10-04-06 |
Margaret McGlynn
BRD | Director/Board Member | 64 | 20-12-06 |
Rachel King
BRD | Director/Board Member | 64 | 18-10-31 |
Richard Douglas
BRD | Director/Board Member | 71 | 10-08-05 |
John Jacobs
CEO | Chief Executive Officer | 57 | 23-01-22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 140,953,466 | 132,964,447 ( 94.33 %) | 1,000,323 ( 0.7097 %) | 94.33 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.40% | 570M | |
+3.13% | 42.11B | |
+48.83% | 40.08B | |
+8.49% | 40B | |
-10.82% | 26.87B | |
+8.26% | 24.58B | |
-23.69% | 18.44B | |
+1.58% | 11.94B | |
+32.83% | 11.66B | |
+6.63% | 11.01B |
- Stock Market
- Equities
- NVAX Stock
- Company Novavax, Inc.